There are three production lines for COVIran Barekat.[22][2] Cumulate production capacity will be 25-30 million doses per month when all lines will start producing.[7] The first line has a capacity of 3-4 million doses per month and started producing as of 15 March 2021.[23][22] The second line has a capacity of 6-8 million doses per month.[22] On 17 August, it was in the process of producing its first batch.[7] The third line has a capacity of 16-20 million doses per month.[22] On 17 August, 95% of its equipment were reported to be prepared and installed and officials in charge aimed to begin its operation as of end of September.[7]